MAIA Biotechnology, Inc.
MAIA
$2.51
$0.17017.27%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -23.49% | -35.43% | -14.64% | -18.12% | 47.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -21.53% | -15.48% | -18.21% | -5.63% | 52.03% |
| Operating Income | 21.53% | 15.48% | 18.21% | 5.63% | -52.03% |
| Income Before Tax | 42.91% | 43.88% | -96.29% | -95.96% | -36.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 42.91% | 43.88% | -96.29% | -95.96% | -36.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 42.91% | 43.88% | -96.29% | -95.96% | -36.12% |
| EBIT | 21.53% | 15.48% | 18.21% | 5.63% | -52.03% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 64.71% | 67.88% | -13.90% | -22.21% | -6.90% |
| Normalized Basic EPS | 64.69% | 67.86% | -13.90% | -22.23% | -6.90% |
| EPS Diluted | 64.71% | 67.88% | -13.90% | -22.21% | -6.90% |
| Normalized Diluted EPS | 64.69% | 67.86% | -13.90% | -22.23% | -6.90% |
| Average Basic Shares Outstanding | 61.74% | 74.72% | 72.32% | 60.35% | 41.18% |
| Average Diluted Shares Outstanding | 61.74% | 74.72% | 72.32% | 60.35% | 41.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |